1. Home
  2. GPI vs LGND Comparison

GPI vs LGND Comparison

Compare GPI & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Group 1 Automotive Inc.

GPI

Group 1 Automotive Inc.

HOLD

Current Price

$326.68

Market Cap

3.9B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$302.15

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPI
LGND
Founded
1995
1987
Country
United States
United States
Employees
N/A
68
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
GPI
LGND
Price
$326.68
$302.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$447.14
$256.29
AVG Volume (30 Days)
197.7K
489.9K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.57%
N/A
EPS Growth
N/A
N/A
EPS
10.85
N/A
Revenue
$11,123,721,000.00
N/A
Revenue This Year
$3.41
$1.25
Revenue Next Year
$3.10
$19.41
P/E Ratio
$30.22
$76.27
Revenue Growth
2.17
N/A
52 Week Low
$279.10
$131.67
52 Week High
$488.39
$326.63

Technical Indicators

Market Signals
Indicator
GPI
LGND
Relative Strength Index (RSI) 55.81 54.83
Support Level $320.55 $181.43
Resistance Level $348.26 $326.63
Average True Range (ATR) 13.14 10.66
MACD 3.34 -3.85
Stochastic Oscillator 71.38 27.60

Price Performance

Historical Comparison
GPI
LGND

About GPI Group 1 Automotive Inc.

Group 1 owns and operates 32 collision centers and 253 automotive dealerships in the US and the UK, offering 36 brands of automobiles altogether. Slightly over half of the stores are in the US with locations mostly in metropolitan areas in 17 states in the Northeast, Southeast, Midwest, and California. Texas alone contributed 31.6% of new-vehicle unit volume in 2025 and the UK 27.6%. Texas, Massachusetts, and California combined was 45.4%. Revenue in 2025 totaled $22.6 billion. The firm entered the UK in 2007 and has 110 stores there contributing about 26% of total revenue. Group 1 was founded in 1995 and is based in Houston.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: